Rizatriptan
Sponsors
Merck Sharp & Dohme LLC, University of Pittsburgh, Clinvest, Organon and Co, Universität Duisburg-Essen
Conditions
Acute MigraineChronic Post-traumatic HeadacheMigraineMigraine, AcuteMigrainous VertigoVestibular Migraine
Phase 2
Phase 3
A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)
CompletedNCT00894556
Start: 2009-06-10End: 2010-01-12Updated: 2024-05-10
A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7)
CompletedNCT01001234
Start: 2009-11-30End: 2011-04-21Updated: 2024-05-07
Maximizing Outcomes in Treating Acute Migraine
CompletedNCT03896009
Start: 2019-03-04End: 2019-12-10Updated: 2023-08-24
Phase 4
Unknown Phase
Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?
CompletedNCT00360282
Start: 2006-08-31End: 2010-03-31Updated: 2014-12-08
Study of Rizatriptan in the Treatment of Acute Attacks of Post-traumatic Headache in U.S. Military Troops
WithdrawnNCT01306266
Start: 2011-02-28End: 2011-08-31Updated: 2015-08-18